Blood and tumor samples for a liquid biopsy test
Part of Cancer clinical trials.
This study collects blood and may also use existing tumor tissue to help develop a liquid biopsy blood test for people with solid (non-blood) cancers. You may qualify if you have a current cancer with tumor in the body and can provide blood samples at set visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 or older and willing to sign consent forms
- Have a non-blood (solid) cancer with tumor currently in your body
- Have tumor material available now or plan an upcoming biopsy or surgery after the first visit
- Be able to provide whole blood at the start and at follow-up visits
- Have not had curative surgery for this cancer before the start of the study visit
- Avoid cancer treatments like chemo, hormone-blocking therapy, or radiation before the start visit
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a simple blood test to look at the genetic makeup of your tumor. The results may help your doctors choose the best treatment for you. You will need to provide a tumor sample or have a biopsy.
This study looks at blood and tumor tissue to find signs (markers) that can help diagnose or better understand metastatic cancer. You may be able to join if you’re getting surgery or a biopsy to remove a tumor and there’s a safe way to collect samples.
This study uses a blood test (liquid biopsy) to find genetic changes in advanced solid tumors. It may help doctors choose the right treatment and monitor how well it works over time.
This study uses a blood test (liquid biopsy) to look for tumor DNA in patients with advanced cancer. It aims to see if this test can help doctors monitor the cancer and make better treatment decisions.
This study measures “circulating tumor markers,” meaning substances from cancer that can show up in blood, to better understand how cancer is doing after treatment. You may join if you recently received cancer care at a participating center and meet basic study and follow-up requirements.
This study collects tumor tissue and related blood tests from people who already need a biopsy or surgery as part of their usual care. Researchers use the samples to learn what drives the tumor and how the tumor environment may affect treatment, which could help develop future therapies.
Hear when a new Non-hematologic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.